Z-1237-2019 Class II Ongoing

Recalled by PerkinElmer Life And Analytical Sciences, Wallac, OY — Turku, N/A

FDA device recall Z-1237-2019 was initiated by PerkinElmer Life And Analytical Sciences, Wallac, OY on Jan 10, 2019 and is designated Class II. Reason for recall: hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations. The recall status is ongoing. Affected quantity: 31 kits (10 in US, 21 in ROW).

Recall details

Product Type
Devices
Report Date
May 8, 2019
Initiation Date
Jan 10, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
31 kits (10 in US, 21 in ROW)

Product description

DELFIA¿ hCG Kit, In Vitro Diagnostic for the determination of human gonadotropin (hCG) Product Code: A007-101 - Product Usage: Quantitative determination of human gonadotrophin (hCG) in serum.

Reason for recall

hCG analyte concentrations may be decreased up to 15- 20% at the lower measuring range of hCG concentrations.

Distribution pattern

Worldwide distribution - US Nationwide distribution. and countries of Austria, Bolivia, UK, Switzerland,Thailand, Finland.

Code information

Kit Lot Numbers: 664891, 666471, 666604 Pack Lot Numbers: 1066489101, 1066647101,1066660401 UDI: (01)06438147009176(17)190430(10)664891 (01)06438147009176(17)190430(10)666471 (01)06438147009176(17)190430(10)666604

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1237-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1237-2019. Report a data issue: hello@regdatalab.com.